Director, Market Insights & Analytics

Overview

A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia.

The Director, Market Insights & Analytics, U.S. Portfolio & Launch Readiness supports U.S. market insights, forecast transition, strategic planning, and launch-readiness analytics for assets approaching commercialization. The role serves as the U.S. commercial bridge between global early-stage forecasting and U.S. launch planning, ensuring assets within approximately two years of expected U.S. launch have clear, pressure‑tested assumptions, planning timelines, market context, analytics requirements, and source‑of‑truth outputs.

This role partners closely with Global Forecasting, U.S. Commercial, Market Insights & Forecasting, Commercial Analytics, Reporting & Decision Support, Finance, Market Access, Medical, Data/Technology, BIS, and other cross‑functional stakeholders to translate global forecast inputs into U.S.

-specific commercial assumptions, strategic planning materials, launch-readiness reporting requirements, and executive-ready decision support.

The Director reports into Market Insights & Forecasting and has dotted‑line accountability to Analytics & Decision Support for dashboard requirements, reporting automation, data structure, and analytical production standards. The role ensures near-launch assets are incorporated into U.S. strategic planning, forecast governance, executive reporting, and future-state commercial intelligence capabilities without duplicating early-stage global forecasting ownership.

This is an individual contributor role that leads through influence across global and U.S. stakeholders, with no direct people‑management responsibility.

• Lead U.S. forecast transition and launch‑readiness planning for assets approaching commercialization, with emphasis on products expected to enter U.S. commercial planning windows within approximately two years of launch.
• Partner with global forecasting teams to understand early‑stage forecast assumptions, market models, epidemiology, patient flow, competitive context, evidence expectations, and key uncertainties.
• Translate global forecast inputs into U.S.
  
  -specific commercial planning assumptions, including market size, patient opportunity, treatment flow, adoption drivers, access considerations, competitive dynamics, launch timing, and scenario ranges.
• Support the Senior Director, Market Insights & Forecasting in developing U.S. forecast assumptions, strategic planning inputs, scenario framing, launch-readiness narratives, risk and opportunity assessments, and senior leadership materials.
• Coordinate U.S. strategic planning timelines, deliverables, assumption‑gathering processes, cross‑functional inputs, review meetings, and consolidated planning materials for near-launch assets.
• Develop and maintain structured handoff processes between global early-stage forecasting and U.S. commercial planning to ensure clear ownership, assumption traceability, documentation, and decision rights.
• Partner with the Director, Analytics & Decision Support to develop launch-readiness dashboards, planning trackers, forecast comparison views, assumption logs, milestone trackers, and source-of-truth reporting outputs.
• Partner with Data/Technology, BIS, Finance, and analytics stakeholders to define reporting requirements, support automation of recurring launch-readiness views, integrate planning inputs, and create scalable reporting structures for assets moving toward commercialization.
• Synthesize primary research, secondary data, competitive intelligence, global assumptions, market access inputs, Medical perspective, and U.S. commercial feedback into clear planning implications and recommended actions.
• Support executive-ready materials for strategic…